Counterpath (CPAH) Posts Narrower Q3 Loss
Get Alerts CPAH Hot Sheet
Join SI Premium – FREE
Counterpath (NASDAQ: CPAH) reported Q3 EPS of ($0.01), versus ($0.07) reported last year. Revenue for the quarter came in at $2.7 million, versus $3 million reported last year.
For earnings history and earnings-related data on Counterpath (CPAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- Goldman Sachs Downgrades Beiersdorf AG (BEI:GR) (BDRFY) to Sell
- Lucid Group reports Q3 2026 production and delivery figures
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share